←
Tom Fuchs75 posts
Tom Fuchs avatar

Tom Fuchs

@FuchsTom

MD PhD | Research Fellow | @AnatNeu_Ams @MScentrum020 @AmsterdamUMC

◷ Joined November 2011▧ 10 Photos and videos
Tom Fuchs avatar
Tom Fuchs@FuchsTom·Jun 12

Grateful for the opportunity to speak with Lisa A. Tomaszewski at Physicians Weekly about our recent work using machine learning to predict disease progression in multiple sclerosis. One idea that came through strongly in our conversation: better algorithms alone are not enough. If predictive tools are going to improve patient care, they must also be transparent, interpretable, globally validated, and designed with the realities of clinical practice in mind. I’m excited to be working at the intersection of neuroscience, clinical medicine, and machine learning as these technologies begin shaping the future of patient care. See the interview here! physiciansweekly.com/post/qa…

NeurologyLive® avatar
⟳ Tom Fuchs retweeted
NeurologyLive®@neurology_live·May 1

🧠📊 New on NeurologyLive®: @FuchsTom, of @amsterdamumc, explores machine learning models designed to predict disease progression in multiple sclerosis using clinically accessible data—focused on usability and clinical decision support. 🔗 Read more 👉 hubs.li/Q04f1lJx0

Post attachment
Tom Fuchs avatar
Tom Fuchs@FuchsTom·Jun 1

Just published! An excellent article by the brilliant Daan de Jong. Dr. de Jong explores practice effects with repeat cognitive assessment and whether this in itself can be used to understand the status of people with multiple sclerosis. link.springer.com/article/10…

Post attachmentPost attachment
Tom Fuchs avatar
Tom Fuchs@FuchsTom·Apr 20

Disease progression in multiple sclerosis can be reliably predicted using clinically accessible information and technology. See our latest publication in Journal of Neurology about the development and validation of the new DAAE-M and ELIE scores! The manuscript: link.springer.com/article/10… The online tools: tomafuchs.com/public-tools/ Thank you to @ECTRIMS, @MScentrum020, @MSBase_Registry, for supporting this work - and to my mentors and collaborators @Mennoke, Eva Strijbis, @JelgerhuisJ, @BiancaGuttman, and Robert Zivadinov

Post attachmentPost attachment
Tom Fuchs avatar
Tom Fuchs@FuchsTom·Feb 23

When considering spinal cord atrophy as a measure of pathology, it is important to also account for natural variability. See this excellent publication by Daan de Jong bit.ly/4tKJpCv

Tom Fuchs avatar
Tom Fuchs@FuchsTom·Feb 23

Cognitive decline can worsen independent of relapse in multiple sclerosis and is best predicted by early neurodegeneration. An important new article by Stefano Ziccardi & Massimiliano Calabrese bit.ly/4c4YrMY

Tom Fuchs avatar
Tom Fuchs@FuchsTom·15 Dec 2025

I had an excellent discussion with Victoria Leavitt and Brett Drummond during this session at @ECTRIMS conference! Looking forward to future advancements worth debating : )

ECTRIMS@ECTRIMS12 Dec 2025

🎙️ “Cognition is a window into otherwise uncaptured disease progression, and that is a reason to measure it. That then allows us to then decide if what we are doing for our patients is right.” Tom Fuchs from @AmsNeuroscience in the latest ECTRIMS Podcast on cognition 🎧 Listen now: bit.ly/48vMjm7 #ECTRIMSPodcast #MultipleSclerosis #Cognition #MSResearch #Neurology #MSCommunity @MStranslate

Post attachment
ECTRIMS avatar
⟳ Tom Fuchs retweeted
ECTRIMS@ECTRIMS·11 Dec 2025

Cognitive symptoms in MS are common—but not always captured well by current tools. In our latest podcast, Vicky Leavitt from @Columbia and Tom Fuchs from @AmsNeuroscience talk about the state of cognition research, if measurement still lags behind clinical need, and how new tools may change the field forever. 🎧 Listen now: Apple: apple.co/4oMh8HY #ECTRIMSPodcast #MultipleSclerosis #Cognition #MSResearch #Neurology #MSCommunity @MStranslate

Post attachmentPost attachmentPost attachment
Tom Fuchs avatar
Tom Fuchs@FuchsTom·26 Sep 2025

Thank you @ECTRIMS for supporting this work, to the committee for honoring us with this award, and to my incredible mentors and collaborators! I am proud of this research, unraveling the functional brain underpinnings of disease progression in people with multiple sclerosis.

Post attachmentPost attachmentPost attachment